Pittsburgh, Pennsylvania, United States Related Funds
Funds with similar focus
| Fund Name | Location |
| 212 | Istanbul, Istanbul, Turkey |
| 7home | Hanoi, Vietnam |
| AAJ Capital LLC | - |
| Allrad Investments | - |
| AlRajhi Partners | - |
| Atlassian | Australia, New South Wales, Sydney |
| Daye Trust | China, Guangdong, Guangzhou |
| EJAM Capital Partners | China, Guangdong, Panyu |
| Fraunhofer-Gesellschaft | Bayern, Germany, Munich |
| Hello Ventures | British Columbia, Canada, Victoria |
| Jingzhi Group | Beijing, Beijing, China |
| Kalamazoo Angels | - |
| Kataweb | Italy, Lazio, Rome |
| Kuok Ventures | Central, Central Region, Singapore |
| Ningbo Ailihesen Guquan Touzi Guanli Hehuo Qiye (Youxian Hehuo) | China, Ningbo, Zhejiang |
| Pioneer Venture Partners | Kirkland, United States, Washington |
| Prime Mont V.C | Beijing, Beijing, China |
| Structure Fund | California, Los Angeles, United States |
| SV Investment Corp | Seoul, Seoul-t'ukpyolsi, South Korea |
| Wainbridge Capital | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Esprit Pharma | $25M | 16 Jan 2007 | New Jersey, United States | ||
Vontu | $10M | 21 Mar 2005 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Esprit Pharma | $25M | 16 Jan 2007 | New Jersey, United States | ||
Vontu | $10M | 21 Mar 2005 | San Francisco, California, United States |
